Real Madrid is facing a growing defensive injury crisis as Eder Militao is set to miss significant time. Militao was substituted by Antonio Rudiger in the 24th minute during Madrid’s 2-0 loss to Celta Vigo.
Medical staff assisted him off the field. Tests revealed a rupture in the biceps femoris tendon of his left leg, impacting the proximal hamstring area.
The club has not specified how long Militao will be out, but estimates suggest he could be sidelined for up to four months. “Following tests conducted on our player Eder Militao by the Real Madrid Medical Services, he has been diagnosed with a rupture of the biceps femoris tendon in the left leg, specifically affecting the proximal tendon,” stated a club announcement. “His progress will be monitored.”
This setback adds to Xabi Alonso’s defensive challenges, with Militao joining Trent Alexander-Arnold, Dani Carvajal, David Alaba, and Ferland Mendy on the injury list. Alexander-Arnold suffered a quad injury during their victory over Athletic Club last Wednesday. These injuries come at a critical time as Madrid prepares for their Champions League match against Manchester City.
Militao has been a key player for Real Madrid this season, making 13 appearances in LaLiga during the 2025-26 campaign. Only eight other players have featured more frequently under Alonso’s management. The timing of these injuries places additional pressure on Alonso as he navigates through crucial fixtures.
Real Madrid’s defensive depth will be tested in upcoming matches due to these injuries. The team must adapt quickly to maintain their competitive edge in both domestic and European competitions. The absence of key defenders like Militao could significantly impact their performance and strategy moving forward.
Madrid’s medical team will closely monitor Militao’s recovery process, hoping for a swift return to action. Meanwhile, Alonso must find solutions within his squad to cope with these challenges and keep their season objectives on track amidst mounting pressure from fans and media alike.